CORNING, N.Y. (WENY) - Corning Inc. will receive a little over $100 million in additional funding for the manufacturing of glass tubing and vials.

The funding comes from the U.S. Department of Health and Human Services' in partnership with the Department of Defense. The company says the money will help the health care industry to address current and future public health challenges.

"Corning's pharmaceutical glass packaging has played a critical role in ensuring the safe and on-time delivery of critical medications," said Brendan Mosher, vice president and general manager, Corning Pharmaceutical Technologies. "Our Valor® Glass and Velocity® Vials are some of the strongest, fastest to fill, and highest-quality pharmaceutical glass vials available. Our products play a critical role in helping to protect patients by improving glass quality, lowering the risk of contamination, and helping to accelerate the delivery of lifesaving treatments."

Corning will continue to expand tube manufacturing in New Jersey and vial manufacturing in North Carolina.